Repository logo

  • Help
  • Log In(current)
    1. Home
    2. NT Health Research
    3. Research and Conference Publications
    4. Targeted Oxygen for Initial Resuscitation of Preterm Infants: The TORPIDO 30/60 Randomized Clinical Trial.
    Details
    Title

    Targeted Oxygen for Initial Resuscitation of Preterm Infants: The TORPIDO 30/60 Randomized Clinical Trial.

    Link to article in PubMed
    https://pubmed.ncbi.nlm.nih.gov/41369162/?otool=iaurydwlib
    Author(s)
    Oei, Ju Lee
    Kirby, Adrienne
    Travadi, Javeed
    Davis, Peter
    Wright, Ian
    Ghadge, Alpana
    Yeung, Carbo
    Cruz, Melinda
    Keech, Anthony
    Hague, Wendy
    Lui, Kei
    Vento, Maximo
    Gordon, Adrienne
    De Waal, Koert
    Chaudhari, Tejasvi
    Hong, Timothy Sui Loong
    Morris, Scott
    Kushnir, Alla
    Bonney, Dennis
    Tracy, Mark
    Kumar, Kishore
    Chhnia, Amitoj Singh
    Baral, Vijay R
    Muniyappa, Prasana
    Cheah, Fook Choe
    Sarnadgouda, Prashant
    Rajadurai, Victor Samuel
    Balakrishnan, Umamaheshwari
    Oleti, Tejo Pratap
    Aldecoa-Bilbao, Victoria
    Couce, Maria-Luz
    Collados, Caridad Tapia
    Fernández, Raquel Escrig
    Moliner, Elisender
    Ruiz Gonzalez, Maria Dolores
    Singhal, Mohit
    Agrawal, Gopal
    Singh, Jaykishore
    Pal, Somalika
    Nayya, Siddarth
    Arora, Rohit
    Amboiram, Prakash
    Simes, John
    Tarnow-Mordi, William
    Abstract
    IMPORTANCE: The most effective initial fraction of inspired oxygen (Fio2) for resuscitating preterm newborns is unknown.
    OBJECTIVE: To compare outcomes of newborns born at 23 to 28 weeks' gestation resuscitated with initial Fio2 of 0.6 vs 0.3.
    DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted in 31 maternity hospitals in 6 countries. Consent by waiver was obtained in Australia, certain institutions in India, and Malaysia; prospective informed consent was obtained in certain institutions in India and all institutions in Singapore, Spain, and the US. Infants due at 23 to 28 weeks' gestation were randomized shortly before birth. Those with congenital abnormalities affecting oxygenation, neurodevelopment, or survival were excluded. Randomization was conducted from September 2018 to September 2024, with follow-up expected to close in September 2026.
    INTERVENTION: Infants were randomized (1:1) to receive an initial Fio2 of 0.6 or 0.3; Fio2 was titrated to meet standard targets for oxygen saturation by pulse oximetry in the first 10 minutes or for clinical needs. Clinicians and those assessing outcomes were not blinded to group assignment.
    MAIN OUTCOMES AND MEASURES: The primary outcome was death and brain injury at 36 weeks' corrected gestational age; secondary outcomes were the individual components of the primary outcome.
    RESULTS: A total of 1641 newborns were randomized. The primary analysis included 728 newborns randomized to receive an Fio2 of 0.6 and 741 to an Fio2 of 0.3 after excluding 172 newborns, mostly for birth after 28 weeks' gestation and transfer to another hospital before birth (54% female). Rates of escalation to Fio2 of 1.0 were similar between the groups (Fio2 of 0.6: 41%; Fio2 of 0.3: 38%). Primary outcome information was ascertained in 1423 newborns (96.9%). Death or brain injury at 36 weeks' corrected gestational age occurred in 330 of 703 newborns (46.9%) assigned to the Fio2 of 0.6 group vs 344 of 720 (47.8%) assigned to the Fio2 of 0.3 group (relative risk, 0.98 [95% CI, 0.89-1.09]).
    CONCLUSIONS AND RELEVANCE: Initiating resuscitation of preterm infants with Fio2 of 0.6 vs 0.3 did not affect the risk of death or brain injury by 36 weeks' corrected gestational age. These results lay a foundation for future trials evaluating the effectiveness and safety of using higher initial Fio2 levels for preterm infant resuscitation.
    TRIAL REGISTRATION: ANZCTR Identifier: ACTRN12618000879268.
    Publication information
    JAMA . 2025 Dec 10. doi: 10.1001/jama.2025.23327. Online ahead of print.
    Date Issued
    2025-12-10
    Project(s)
    Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on Outcome
    Type
    Journal Article
    Journal Title
    JAMA
    DOI
    10.1001/jama.2025.23327
    Permanent link to this record
    https://hdl.handle.net/10137/14877
    ISSN
    1538-3598
    Owning collection
    Research and Conference Publications

    NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

    © 2025 Northern Territory Government of Australia